Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.

Photys

(To Be Hired)

Bryan Song

Ed Holson

Emma Seabrook

The Leadership Team at Photys plays a crucial role in steering the company's strategic vision and operational execution. Comprised of the CEO, CBO, and CSO, the team is responsible for driving innovation in the development of bifunctional small molecules, fostering partnerships, and ensuring alignment between scientific research and business objectives to advance therapeutic solutions in protein modulation.

��

Leadership Team

About

Team members

Other teams at Photys

Scientific Team

Administrative and Support

��������